Project Grant R21AI199737
- Summary of Federal Project Grant Award The University of Washington received a $765,194 Project Grant from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), effective April 9, 2026, with an ultimate completion date of March 31, 2031. This research project will characterize the upper intestinal microbiota during human cholera infection and define the mechanisms by which host microbes impact disease severity....
- Federal Grant Award Summary Wayne State University received a $1,341,058 Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), effective February 13, 2026 through January 31, 2031. This research initiative addresses the critical clinical challenge of multi-drug resistant Staphylococcus aureus (MRSA) infections by investigating phage-antibiotic combinations (PAC) as a novel therapeutic...
- Federal Grant Award Summary Wayne State University received a $455,719 Project Grant award dated April 3, 2026, from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855) to investigate mechanisms underlying phage-antibiotic synergy and resistance in daptomycin-resistant Enterococcus faecium. The research addresses the critical clinical challenge of multidrug-resistant E. faecium infections refractory to...
- Federal Grant Award Summary The University of Michigan received a $411,780 Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), with an award date of February 3, 2026, and completion date of January 31, 2028. The research project, titled "Deciphering Virulence Determinants of Human-Pathogenic Atypical Toxoplasma Gondii," focuses on identifying and characterizing the molecular...
- Federal Grant Award Summary The National Institute of Allergy and Infectious Diseases (NIAID) awarded Indiana University a $503,887 Project Grant under the Allergy and Infectious Diseases Research program (CFDA 93.855) to develop innovative therapeutic strategies targeting Vibrio bacterial infections. The award, dated September 1, 2025, with an ultimate completion date of August 31, 2026, funds research directed by co-principal investigators Dr. Jon Paczkowski and Dr. Julia Van Kessel to advance...
- Federal Grant Award Summary The National Institute of Allergy and Infectious Diseases (NIAID) awarded the Regents of the University of Michigan a $186,600 Project Grant under the Allergy and Infectious Diseases Research program (CFDA 93.855) on May 6, 2026, with a completion date of April 30, 2028. This research initiative, titled "Human Astrovirus Interactions with the Intestinal Epithelial Barrier," investigates the mechanisms by which human astroviruses (HAStV) compromise the...
- Federal Project Grant Award Summary Tufts University School of Medicine received a $453,750 Project Grant from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), effective August 1, 2025 through July 31, 2027. The grant funds research to investigate mechanisms by which bacteriophages evade cyclic oligonucleotide-based antiviral defense systems in bacteria, with specific focus on how phage proteins antagonize...
- Federal Grant Award Summary The National Institute of Allergy and Infectious Diseases (NIAID) awarded The Washington University a Project Grant totaling $715,894 under the Allergy and Infectious Diseases Research program (CFDA 93.855) on August 8, 2025, for a five-year research initiative extending through July 31, 2030. This award funds fundamental biomedical research investigating the influence of microbial metabolites on mitosome function in Cryptosporidium parvum, a parasitic pathogen...
- Federal Grant Award Summary The National Institute of Allergy and Infectious Diseases (NIAID) awarded the Regents of the University of Michigan a $411,078 Project Grant under the Allergy and Infectious Diseases Research program (CFDA 93.855) for the period April 1, 2026 through March 31, 2028. This award supports research to discover and characterize novel antifungal compounds derived from symbiotic bacteria—microorganisms that naturally co-exist with eukaryotic hosts—as potential therapeutic...
- Federal Project Grant Award Summary Northwestern University's Sponsored Research Division received a $240,000 project grant from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), awarded September 5, 2025, with completion targeted for August 31, 2027. The research investigates bile resistance mechanisms in Pseudomonas aeruginosa (PA), a leading cause of healthcare-associated infections and bloodstream...
Wayne State University received a $225,600 Project Grant from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), awarded May 20, 2026, with a completion date of April 30, 2028. The research initiative, conducted at the university's Detroit, Michigan facility, focuses on identifying Vibrio cholerae colonization and transmission factors in aquatic hosts using zebrafish as a natural model organism. The project will employ transposon sequencing (Tn-seq) screening and targeted gene deletion methods to characterize bacterial genes essential for fish colonization, followed by comparative testing in mammalian models to assess the relevance of identified factors to human infections. This investigator-initiated research project aims to advance fundamental understanding of the infectious processes and virulence mechanisms employed by pandemic O1 Vibrio cholerae strains. By leveraging zebrafish as a natural host model that maintains mature intestinal microbiota and immune responses—advantages not available in traditional mammalian models—the research will generate scientific knowledge on pathogenic mechanisms underlying cholera transmission and infection. The findings are intended to contribute to improved public health approaches for addressing diarrheal diseases caused by Vibrio cholerae and related waterborne pathogens.Federal Grant Award Summary
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $225.6k | 5/22/26 |